Eintrag weiter verarbeiten
Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo
Gespeichert in:
| Zeitschriftentitel: | Clinical Cancer Research |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , |
| In: | Clinical Cancer Research, 11, 2005, 17, S. 6333-6341 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Association for Cancer Research (AACR)
|
| Schlagwörter: |
| author_facet |
Gao, Lifang Zhang, Ling Hu, Jiadi Li, Feng Shao, Yueting Zhao, Dan Kalvakolanu, Dhananjaya V. Kopecko, Dennis J. Zhao, Xuejian Xu, De-Qi Gao, Lifang Zhang, Ling Hu, Jiadi Li, Feng Shao, Yueting Zhao, Dan Kalvakolanu, Dhananjaya V. Kopecko, Dennis J. Zhao, Xuejian Xu, De-Qi |
|---|---|
| author |
Gao, Lifang Zhang, Ling Hu, Jiadi Li, Feng Shao, Yueting Zhao, Dan Kalvakolanu, Dhananjaya V. Kopecko, Dennis J. Zhao, Xuejian Xu, De-Qi |
| spellingShingle |
Gao, Lifang Zhang, Ling Hu, Jiadi Li, Feng Shao, Yueting Zhao, Dan Kalvakolanu, Dhananjaya V. Kopecko, Dennis J. Zhao, Xuejian Xu, De-Qi Clinical Cancer Research Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo Cancer Research Oncology |
| author_sort |
gao, lifang |
| spelling |
Gao, Lifang Zhang, Ling Hu, Jiadi Li, Feng Shao, Yueting Zhao, Dan Kalvakolanu, Dhananjaya V. Kopecko, Dennis J. Zhao, Xuejian Xu, De-Qi 1078-0432 1557-3265 American Association for Cancer Research (AACR) Cancer Research Oncology http://dx.doi.org/10.1158/1078-0432.ccr-05-0148 <jats:title>Abstract</jats:title> <jats:p>Purpose: Signal transducer and activator of transcription 3 (Stat3) is constitutively activated in a variety of cancers and it is a common feature of prostate cancer. Thus, Stat3 represents a promising molecular target for tumor therapy. We applied a DNA vector–based Stat3-specific RNA interference approach to block Stat3 signaling and to evaluate the biological consequences of Stat3 down-modulation on tumor growth using a mouse model.</jats:p> <jats:p>Experimental Design: To investigate the therapeutic potential of blocking Stat3 in cancer cells, three small interfering RNAs (siRNA; Stat3-1, Stat3-2, and Stat3-3) specific for different target sites on Stat3 mRNA were designed and used with a DNA vector–based RNA interference approach expressing short hairpin RNAs to knockdown Stat3 expression in human prostate cancer cells in vitro as well as in vivo.</jats:p> <jats:p>Results: Of the three equivalently expressed siRNAs, only Stat3-3 and Stat3-2, which target the region coding for the SH2 domain and the coiled-coil domain, respectively, strongly suppressed the expression of Stat3 in PC3 and LNCaP cells. The Stat3-1 siRNA, which targeted the DNA-binding domain, exerted no effect on Stat3 expression, indicating that the gene silencing efficiency of siRNA may be dependent on the local structure of Stat3 mRNA. The Stat3 siRNAs down-regulated the expression of Bcl-2 (an antiapoptotic protein), and cyclin D1 and c-Myc (cell growth activators) in prostate cancer cells. Inhibition of Stat3 and its related genes was accompanied by growth suppression and induction of apoptosis in cancer cells in vitro and in tumors implanted in nude mice.</jats:p> <jats:p>Conclusions: These data indicate that Stat3 signaling is a promising molecular target for prostate cancer therapy and that vector-based Stat3 siRNA may be useful as a therapeutic agent for treatment of prostate cancer.</jats:p> Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor <i>In vivo</i> Clinical Cancer Research |
| doi_str_mv |
10.1158/1078-0432.ccr-05-0148 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDc4LTA0MzIuY2NyLTA1LTAxNDg |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDc4LTA0MzIuY2NyLTA1LTAxNDg |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
American Association for Cancer Research (AACR), 2005 |
| imprint_str_mv |
American Association for Cancer Research (AACR), 2005 |
| issn |
1557-3265 1078-0432 |
| issn_str_mv |
1557-3265 1078-0432 |
| language |
English |
| mega_collection |
American Association for Cancer Research (AACR) (CrossRef) |
| match_str |
gao2005downregulationofsignaltransducerandactivatoroftranscription3expressionusingvectorbasedsmallinterferingrnassuppressesgrowthofhumanprostatetumorinvivo |
| publishDateSort |
2005 |
| publisher |
American Association for Cancer Research (AACR) |
| recordtype |
ai |
| record_format |
ai |
| series |
Clinical Cancer Research |
| source_id |
49 |
| title |
Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo |
| title_unstemmed |
Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo |
| title_full |
Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo |
| title_fullStr |
Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo |
| title_full_unstemmed |
Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo |
| title_short |
Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo |
| title_sort |
down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering rnas suppresses growth of human prostate tumor <i>in vivo</i> |
| topic |
Cancer Research Oncology |
| url |
http://dx.doi.org/10.1158/1078-0432.ccr-05-0148 |
| publishDate |
2005 |
| physical |
6333-6341 |
| description |
<jats:title>Abstract</jats:title>
<jats:p>Purpose: Signal transducer and activator of transcription 3 (Stat3) is constitutively activated in a variety of cancers and it is a common feature of prostate cancer. Thus, Stat3 represents a promising molecular target for tumor therapy. We applied a DNA vector–based Stat3-specific RNA interference approach to block Stat3 signaling and to evaluate the biological consequences of Stat3 down-modulation on tumor growth using a mouse model.</jats:p>
<jats:p>Experimental Design: To investigate the therapeutic potential of blocking Stat3 in cancer cells, three small interfering RNAs (siRNA; Stat3-1, Stat3-2, and Stat3-3) specific for different target sites on Stat3 mRNA were designed and used with a DNA vector–based RNA interference approach expressing short hairpin RNAs to knockdown Stat3 expression in human prostate cancer cells in vitro as well as in vivo.</jats:p>
<jats:p>Results: Of the three equivalently expressed siRNAs, only Stat3-3 and Stat3-2, which target the region coding for the SH2 domain and the coiled-coil domain, respectively, strongly suppressed the expression of Stat3 in PC3 and LNCaP cells. The Stat3-1 siRNA, which targeted the DNA-binding domain, exerted no effect on Stat3 expression, indicating that the gene silencing efficiency of siRNA may be dependent on the local structure of Stat3 mRNA. The Stat3 siRNAs down-regulated the expression of Bcl-2 (an antiapoptotic protein), and cyclin D1 and c-Myc (cell growth activators) in prostate cancer cells. Inhibition of Stat3 and its related genes was accompanied by growth suppression and induction of apoptosis in cancer cells in vitro and in tumors implanted in nude mice.</jats:p>
<jats:p>Conclusions: These data indicate that Stat3 signaling is a promising molecular target for prostate cancer therapy and that vector-based Stat3 siRNA may be useful as a therapeutic agent for treatment of prostate cancer.</jats:p> |
| container_issue |
17 |
| container_start_page |
6333 |
| container_title |
Clinical Cancer Research |
| container_volume |
11 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792347443246923787 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:55:20.907Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Down-Regulation+of+Signal+Transducer+and+Activator+of+Transcription+3+Expression+Using+Vector-Based+Small+Interfering+RNAs+Suppresses+Growth+of+Human+Prostate+Tumor+In+vivo&rft.date=2005-09-01&genre=article&issn=1557-3265&volume=11&issue=17&spage=6333&epage=6341&pages=6333-6341&jtitle=Clinical+Cancer+Research&atitle=Down-Regulation+of+Signal+Transducer+and+Activator+of+Transcription+3+Expression+Using+Vector-Based+Small+Interfering+RNAs+Suppresses+Growth+of+Human+Prostate+Tumor+%3Ci%3EIn+vivo%3C%2Fi%3E&aulast=Xu&aufirst=De-Qi&rft_id=info%3Adoi%2F10.1158%2F1078-0432.ccr-05-0148&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792347443246923787 |
| author | Gao, Lifang, Zhang, Ling, Hu, Jiadi, Li, Feng, Shao, Yueting, Zhao, Dan, Kalvakolanu, Dhananjaya V., Kopecko, Dennis J., Zhao, Xuejian, Xu, De-Qi |
| author_facet | Gao, Lifang, Zhang, Ling, Hu, Jiadi, Li, Feng, Shao, Yueting, Zhao, Dan, Kalvakolanu, Dhananjaya V., Kopecko, Dennis J., Zhao, Xuejian, Xu, De-Qi, Gao, Lifang, Zhang, Ling, Hu, Jiadi, Li, Feng, Shao, Yueting, Zhao, Dan, Kalvakolanu, Dhananjaya V., Kopecko, Dennis J., Zhao, Xuejian, Xu, De-Qi |
| author_sort | gao, lifang |
| container_issue | 17 |
| container_start_page | 6333 |
| container_title | Clinical Cancer Research |
| container_volume | 11 |
| description | <jats:title>Abstract</jats:title> <jats:p>Purpose: Signal transducer and activator of transcription 3 (Stat3) is constitutively activated in a variety of cancers and it is a common feature of prostate cancer. Thus, Stat3 represents a promising molecular target for tumor therapy. We applied a DNA vector–based Stat3-specific RNA interference approach to block Stat3 signaling and to evaluate the biological consequences of Stat3 down-modulation on tumor growth using a mouse model.</jats:p> <jats:p>Experimental Design: To investigate the therapeutic potential of blocking Stat3 in cancer cells, three small interfering RNAs (siRNA; Stat3-1, Stat3-2, and Stat3-3) specific for different target sites on Stat3 mRNA were designed and used with a DNA vector–based RNA interference approach expressing short hairpin RNAs to knockdown Stat3 expression in human prostate cancer cells in vitro as well as in vivo.</jats:p> <jats:p>Results: Of the three equivalently expressed siRNAs, only Stat3-3 and Stat3-2, which target the region coding for the SH2 domain and the coiled-coil domain, respectively, strongly suppressed the expression of Stat3 in PC3 and LNCaP cells. The Stat3-1 siRNA, which targeted the DNA-binding domain, exerted no effect on Stat3 expression, indicating that the gene silencing efficiency of siRNA may be dependent on the local structure of Stat3 mRNA. The Stat3 siRNAs down-regulated the expression of Bcl-2 (an antiapoptotic protein), and cyclin D1 and c-Myc (cell growth activators) in prostate cancer cells. Inhibition of Stat3 and its related genes was accompanied by growth suppression and induction of apoptosis in cancer cells in vitro and in tumors implanted in nude mice.</jats:p> <jats:p>Conclusions: These data indicate that Stat3 signaling is a promising molecular target for prostate cancer therapy and that vector-based Stat3 siRNA may be useful as a therapeutic agent for treatment of prostate cancer.</jats:p> |
| doi_str_mv | 10.1158/1078-0432.ccr-05-0148 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDc4LTA0MzIuY2NyLTA1LTAxNDg |
| imprint | American Association for Cancer Research (AACR), 2005 |
| imprint_str_mv | American Association for Cancer Research (AACR), 2005 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 1557-3265, 1078-0432 |
| issn_str_mv | 1557-3265, 1078-0432 |
| language | English |
| last_indexed | 2024-03-01T17:55:20.907Z |
| match_str | gao2005downregulationofsignaltransducerandactivatoroftranscription3expressionusingvectorbasedsmallinterferingrnassuppressesgrowthofhumanprostatetumorinvivo |
| mega_collection | American Association for Cancer Research (AACR) (CrossRef) |
| physical | 6333-6341 |
| publishDate | 2005 |
| publishDateSort | 2005 |
| publisher | American Association for Cancer Research (AACR) |
| record_format | ai |
| recordtype | ai |
| series | Clinical Cancer Research |
| source_id | 49 |
| spelling | Gao, Lifang Zhang, Ling Hu, Jiadi Li, Feng Shao, Yueting Zhao, Dan Kalvakolanu, Dhananjaya V. Kopecko, Dennis J. Zhao, Xuejian Xu, De-Qi 1078-0432 1557-3265 American Association for Cancer Research (AACR) Cancer Research Oncology http://dx.doi.org/10.1158/1078-0432.ccr-05-0148 <jats:title>Abstract</jats:title> <jats:p>Purpose: Signal transducer and activator of transcription 3 (Stat3) is constitutively activated in a variety of cancers and it is a common feature of prostate cancer. Thus, Stat3 represents a promising molecular target for tumor therapy. We applied a DNA vector–based Stat3-specific RNA interference approach to block Stat3 signaling and to evaluate the biological consequences of Stat3 down-modulation on tumor growth using a mouse model.</jats:p> <jats:p>Experimental Design: To investigate the therapeutic potential of blocking Stat3 in cancer cells, three small interfering RNAs (siRNA; Stat3-1, Stat3-2, and Stat3-3) specific for different target sites on Stat3 mRNA were designed and used with a DNA vector–based RNA interference approach expressing short hairpin RNAs to knockdown Stat3 expression in human prostate cancer cells in vitro as well as in vivo.</jats:p> <jats:p>Results: Of the three equivalently expressed siRNAs, only Stat3-3 and Stat3-2, which target the region coding for the SH2 domain and the coiled-coil domain, respectively, strongly suppressed the expression of Stat3 in PC3 and LNCaP cells. The Stat3-1 siRNA, which targeted the DNA-binding domain, exerted no effect on Stat3 expression, indicating that the gene silencing efficiency of siRNA may be dependent on the local structure of Stat3 mRNA. The Stat3 siRNAs down-regulated the expression of Bcl-2 (an antiapoptotic protein), and cyclin D1 and c-Myc (cell growth activators) in prostate cancer cells. Inhibition of Stat3 and its related genes was accompanied by growth suppression and induction of apoptosis in cancer cells in vitro and in tumors implanted in nude mice.</jats:p> <jats:p>Conclusions: These data indicate that Stat3 signaling is a promising molecular target for prostate cancer therapy and that vector-based Stat3 siRNA may be useful as a therapeutic agent for treatment of prostate cancer.</jats:p> Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor <i>In vivo</i> Clinical Cancer Research |
| spellingShingle | Gao, Lifang, Zhang, Ling, Hu, Jiadi, Li, Feng, Shao, Yueting, Zhao, Dan, Kalvakolanu, Dhananjaya V., Kopecko, Dennis J., Zhao, Xuejian, Xu, De-Qi, Clinical Cancer Research, Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo, Cancer Research, Oncology |
| title | Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo |
| title_full | Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo |
| title_fullStr | Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo |
| title_full_unstemmed | Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo |
| title_short | Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo |
| title_sort | down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering rnas suppresses growth of human prostate tumor <i>in vivo</i> |
| title_unstemmed | Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo |
| topic | Cancer Research, Oncology |
| url | http://dx.doi.org/10.1158/1078-0432.ccr-05-0148 |